Browsing by Author "Ferreira, André C."
Now showing items 9-18 of 18
-
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
Dias, Suelen da Silva Gomes et al. | Date Issued: 2020 -
Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation
Souza, Thiago Moreno L. et al. | Date Issued: 2023O artigo trata do desenvolvimento de um antiviral de uso oral contra a Covid-19. A substância, batizada de MB-905, foi purificada a partir da cinetina e demonstrou-se eficaz para inibir a replicação do Sars-CoV-2 em linhagens ... -
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
Ferreira, André C. et al. | Date Issued: 2021 -
Severe influenza infection is associated with inflammatory programmed cell death in infected macrophages
Ferreira, André C. et al. | Date Issued: 2023 -
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae
Ferreira, André C. et al. | Date Issued: 2017 -
The Chemokine CCL5 Inhibits the Replication of Influenza A Virus Through SAMHD1 Modulation
Silva, Thauane et al. | Date Issued: 2021 -
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
Sacramento, Carolina Q. et al. | Date Issued: 2017 -
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells
Sacramento, Carolina Q. et al. | Date Issued: 2022 -
VIP plasma levels associate with survival in severe COVID-19 patients, correlatingwith protective effects in SARS-CoV-2-infected cells
Temerozo, Jairo R. et al. | Date Issued: 2022 -
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
Freitas, Caroline S. de et al. | Date Issued: 2019